SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-275066
Filing Date
2022-11-01
Accepted
2022-11-01 17:19:05
Documents
21
Period of Report
2022-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d411684d8k.htm   iXBRL 8-K 34425
2 EX-1.1 d411684dex11.htm EX-1.1 202237
3 EX-1.2 d411684dex12.htm EX-1.2 14129
4 EX-5.1 d411684dex51.htm EX-5.1 9082
5 EX-99.1 d411684dex991.htm EX-99.1 10241
9 GRAPHIC g41168429_snap1.jpg GRAPHIC 8667
10 GRAPHIC g411684g1028083103931.jpg GRAPHIC 2021
11 GRAPHIC g411684g1028083104337.jpg GRAPHIC 7169
12 GRAPHIC g411684g1101081636085.jpg GRAPHIC 3397
13 GRAPHIC g411684g1101082917274.jpg GRAPHIC 3238
  Complete submission text file 0001193125-22-275066.txt   502873

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nuvl-20221031.xsd EX-101.SCH 2861
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nuvl-20221031_lab.xml EX-101.LAB 18739
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nuvl-20221031_pre.xml EX-101.PRE 11711
15 EXTRACTED XBRL INSTANCE DOCUMENT d411684d8k_htm.xml XML 3469
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 221351499
SIC: 2834 Pharmaceutical Preparations